Website Header with Language Selector and Dropdowns

Chemical Name: (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(tosyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate.

Country of Origin: India

Product Category:Diflorasone Diacetate Impurities


Diflorasone 17-Propionte 21-Tosylte is identified by CAS No. NA and is chemically known as (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(tosyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate.

Diflorasone 17-Propionte 21-Tosylte is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Diflorasone Diacetate.

Page Keywords: Buy Diflorasone 17-Propionte 21-Tosylte | Purchase Diflorasone 17-Propionte 21-Tosylte | Diflorasone 17-Propionte 21-Tosylte suppliers | Diflorasone 17-Propionte 21-Tosylte manufacturers | Diflorasone 17-Propionte 21-Tosylte price | Diflorasone 17-Propionte 21-Tosylte Importer | Diflorasone 17-Propionte 21-Tosylte Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-DFDT-02
CAS No: 2557-49-5
Mol Wt: 410.5
Mol F: C22H28F2O5
Inv. Status: Custom Synthesis
CAT No: CL-DFDT-03
CAS No: 3826-17-3
Mol Wt: 452.5
Mol F: C24H30F2O6
Inv. Status: Custom Synthesis
CAT No: CL-DFDT-01
CAS No: 33564-31-7
Mol Wt: 494.5
Mol F: C26H32F2O7
Inv. Status: Custom Synthesis
CAT No: CL-DFDT-04
CAS No: NA
Mol Wt: 511
Mol F: C26H32ClFO7
Inv. Status: Custom Synthesis
Address(India):

Plot No. A-737/2, TTC Industrial area,
MIDC, Kopar Khairne, Navi Mumbai, INDIA, 400710

           
Address(Bangladesh):

House No. - 12, Road No. - 17, Nikunja -2,
Khilkhet, Dhaka-1230, Bangladesh.

Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.